Health Canada
Symbol of the Government of Canada

Common menu bar links

Drugs and Health Products

Description of the Figure 5: Sample folder structure for DMF Type III - Excipients

Figure 5 displays the sample module 1 to 3 folder structure requirements for a Drug Master File Type III regulatory activity. The Dossier Identifier should be "HC6-24-" followed by a letter and seven numbers.

  • Followed by, subfolder:
    • m1
  • Sub-subfolders:
    • 1.0 Correspondance
      • 1.0.1 Cover Letter
      • 1.0.3 Copy of Health Canada Issued Correspondence
      • 1.0.4 Health Canada Solicited Information
      • 1.0.7 General Note to Reviewer
    • 1.1 Table of Contents
    • 1.2 Administrative Information
      • 1.2.1 Application Form
      • 1.2.2 Fee FormsFootnote 1
      • 1.2.3 Certification and Attestation Forms
      • 1.2.5 Compliance and Site Information
      • 1.2.6 Authorization for Sharing Information
      • 1.2.7 International Information
      • 1.2.9 Other Administration Information
    • 1.3 Product Information
      • 1.3.6 Certified Product Information Document
  • Subfolder:
    • m3
  • Sub-subfolders:
    • 3.1 Table of Contents of Module 3
    • 3.2 Body of Data
      • 3.2.P Drug Product
        • 3.2.P.4 Control of Excipients [Excipient X]
        • 3.2.P.4 Control of Excipients [Excipient Y]
        • 3.2.P.4 Control of Excipients [Excipient Z]
          • 3.2.P.4.1 Specifications
          • 3.2.P.4.2 Analytical Procedures
          • 3.2.P.4.3 Validation of Analytical Procedures
          • 3.2.P.4.4 Justification of Specifications
          • 3.2.P.4.5 Excipients of Human or Animal Origin
          • 3.2.P.4.6 Novel Excipients

Footnotes

Footnote 1

Companies must ensure that no credit card, wire or cheque payment information is included with electronic data. The document that contains the credit card, wire or cheque payment information should be provided in paper only with the cover letter and the CD.

Return to footnote 1 referrer